Retatrutide is the most advanced triple GLP-1/GIP/glucagon receptor agonist research peptide available in Canada in 2026. If you are looking to buy Retatrutide in Canada, Boreals Peptides is the country's premier domestic supplier — stocking Retatrutide in both pen format and vial format with Canada Post Xpresspost delivery to all Canadian provinces.
Retatrutide (LY3437943) was developed by Eli Lilly as a triple receptor agonist targeting GLP-1, GIP and glucagon receptors simultaneously. Unlike Tirzepatide (Mounjaro), which targets two receptors, Retatrutide's triple mechanism makes it the most advanced research compound in its class. Phase 2 clinical trials showed an average 24.2% result over 48 weeks at the highest dose — more than any other GLP-1 compound studied. Phase 3 TRIUMPH trials are ongoing with FDA approval expected in late 2026 to early 2027. Health Canada approval is expected to follow in 2027–2028.
For Canadian researchers, buying Retatrutide in Canada from a domestic supplier like Boreals Peptides means receiving orders via Canada Post Xpresspost in 1–3 business days — far faster than international suppliers who ship from the USA, China or Europe.
Boreals Peptides was built specifically for Canadian researchers who need fast, reliable domestic access to pharmaceutical-grade Retatrutide. Here is what sets Boreals Peptides apart from every other Canadian Retatrutide supplier:
Boreals Peptides stocks Retatrutide in both pen and vial format. The Retatrutide Synedica 40mg pen (CA$234.99) is the most convenient option — pre-loaded with pharmaceutical-grade Retatrutide, requiring no reconstitution, no bacteriostatic water and no separate syringes. Canadian researchers simply attach a pen needle and the pen is ready to use. The pen format eliminates the most common source of research errors — incorrect reconstitution — and is ideal for researchers who travel between Canadian provinces or internationally.
Vial format remains popular among Canadian researchers who need maximum dosing flexibility or want the lowest cost per mg. Boreals Peptides stocks Retatrutide in 10mg (CA$149.99), 20mg (CA$189.99) and 40mg (CA$219.99) vials for researchers who prefer traditional reconstitution protocols.
Boreals Peptides offers competitive CAD pricing on all Retatrutide products for Canadian researchers:
Buying Retatrutide from Boreals Peptides Canada is straightforward. Browse the Retatrutide category and choose between pen format and vial format. Add to cart and proceed to checkout. Enter your Canadian delivery address and postal code. Choose Interac e-Transfer or Bitcoin as your payment method. Boreals Peptides will send payment details by email or WhatsApp within minutes. Once payment is confirmed, your Retatrutide order is dispatched via Canada Post Xpresspost within 24 hours.
Both Retatrutide and Tirzepatide are available at Boreals Peptides with Canada Post Xpresspost delivery. Retatrutide targets three receptors — GLP-1, GIP and glucagon. Tirzepatide targets two — GLP-1 and GIP. Phase 2 clinical data shows Retatrutide produced 24.2% results versus approximately 20.9% for Tirzepatide. Canadian researchers studying advanced metabolic compounds consistently choose Retatrutide when the most advanced option is required. Both compounds are in stock at Boreals Peptides in pen and vial format.
Boreals Peptides ships Retatrutide to all Canadian provinces via Canada Post Xpresspost. Ontario (1–2 days), British Columbia (1–2 days), Alberta (1–2 days), Quebec (2–3 days), Manitoba (2 days), Saskatchewan (2 days), Nova Scotia (2–3 days), New Brunswick (2–3 days), Newfoundland (3 days) and Prince Edward Island (2–3 days). Free shipping on all orders over CA$200.
All Boreals Peptides Retatrutide products are sold strictly for research and development purposes only. Not for human or veterinary use. Retatrutide is not approved by Health Canada for human administration. By purchasing, the buyer confirms they are a qualified researcher and that compounds will be used exclusively for legitimate research purposes in a laboratory setting.
